1Jones E, Dahm-Vicker M, Golgher D, et al. CD25 ^+ regulatory T ceils and tumor immunity [ J ]. Immunol Lett, 2003,85 (2) :141-143.
2Ferrone S, Whiteside T L. Tumor microenvironment and immune escape[ J]. Surg Oncot Clin N Am,2007,16(4) :755- 774.
3Fontenot J D, Gavin M A, Rudensky A Y. Foxp3 programs the development and function of CD4^+ CD25 ^+ regulatory T cells[J]. Nat Immunol,2003,4(4) :330-336.
4Andersson J, Boasso A, Nilsson J, et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients [ J]. J Immunol, 2005, 174 (6) :3143-3147.
5Paust S, Cantor H. Regulatory T cells and autoimmune disease[ J]. Immunol Rev,2005,204:195-207.
6Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD4 ^+CD25 ^+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity and transplantation tolerance [ J ]. Immunol Rev, 2001,182 : 18-32.
7Oswald-Richter K,Grill S M, Shariat N, et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells [ J]. PLoS Biol,2004,2 (7) : E198.
8Choileain N N, Redmond H P. Regulatory T-cells and autoimmunity [ J ]. J Surg Res,2006,130 ( 1 ) : 124-135.
9Bharat A, Fields R C, Mohanakumar T. Regulatory T cell-mediated transplantation tolerance [ J ]. Immunol Res, 2005,33 (3) :195-212.
10Waldmann H,Graca L,Adams E,et al. Regulatory T cells in transplantation tolerance [ J ]. Curr Top Microbiol Immunol, 2005,293 : 249 -264
二级参考文献28
1SAKAGUCHI S, SAKAGUCHI N, ASANO M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[ J ]. J Immunol, 1995, 155(3): 1151-1164.
2BAECHER-ALLAN C, BROWN J A, FREEMAN G J, et al. CD4^+CD25 high regulatory cells in human peripheral blood[J]. J Immunol,2001, 167(3) : 1245 - 1253.
3FUJIO K, OKAMOTO A, TAHARA H, et al. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease[J]. J Immunol, 2004, 173(3) : 2118 -2125.
4MAKITA S, KANAI T, OSHIMA S, et al. CD4 + CD25bfight T cellsin human intestinal lamina pmpria as regulatory cells[J]. J Immunol,2004, 173(5): 3119-3130.
5WOLF A M, WOLF D, STEURER M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [ J ]. Clin Cancer Res,2003,9(2) : 606 -612.
6ONIZUKA S, TAWARA I, SHIMIZU J, et al. Tumor rejection by in vivo administration of anti-CD25 ( interleukin-2 receptor alpha) monoclonal antibody[J]. Cancer Res, 1999, 59(13) : 3128 - 3133.
7SHIMIZU J, YAMAZAKI S, SAKAGUCHI S, Induction of tumor immunity by removing CD25^+ CD4^+ T cells : a common basis between tumor immunity and autoimmunity[ J ]. J Immunol, 1999, 163 (10) :5211 - 5218.
8DIECKMANN D, PLOTYNER H, BERCHTOLD S, et al. Ex vivo isolation and characterization of CD4^(+) CD25^(+) T cells with regulatory properties from human blood[J]. J Exp Med, 2001, 193(11) : 1303 -1310.
9ICHIHARA F, KONO K, TAKAHASHI A, et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers [ J ]. Clin Cancer Res, 2003, 9(12) : 4404 -4408.
10JONULEIT H, SCHMITY E, STASSEN M, et al. Identification and functional characterization of human CD4^(+) CD25^(+) T cells with regulatory properties isolated from peripheral blood [J]. J Exp Med,2001, 193( 11 ) : 1285 - 1294.
3Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas ( Apo-1/CD95 ) ligand : implications for tumor immune escape [ J ]. Science, 1996,274 ( 529 ) : 1363- 1366.
4Ryan A E, Shanahan F, OConnell J, et al. Fas ligand promotes tumor immune evasion of colon cancer in vivo [ J ]. Cancer Biol, 2006,5(3) :246-249.
5Takahama Y, Yamada Y, Emoto K, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas [ J ]. Gastric Cancer, 2002,5(2) :61-68.
6Salama P, Phillips M, Grieu F, et al. Tumor-infiltrating FOXP3^+ T regulatory cells show strong prognostic significance in colorectal cancer [ J ]. J Clin Oncol, 2009,27 ( 2 ) : 186-192.
7Aptsiauri N, Carretero R, Garcia Lora A, et al. Regressing and progressing metastatic lesions: resistance to immunotherapy is .predetermined by irreversible HLA class I antigen alterations [ J ]. Cancer Immunol Immunother, 2008,57 ( 11 ) : 1727-1733.
8Shimura T, Suehiro T, Suzuki H, et al. Peptides derived from a soluble molecule of the human leukocyte antigen (HLA) class I cause apoptosis in gastric cancer cell lines [J]. Dig Dis Sci, 2009,54(1 ) :63-69.
9Wolf AM,Wolf D,Steurer M,et al.Increase of regulatory T cells in the peripheral blood of cancer patients[J].Clin Cancer Res,2003,9(2):606-12.
10Hall BM.Mechanisms of induction of tolerance to organ allografts[J].Crit Rev Immunol,2000,20(4):267-324.
